Antibodies
2 June 2015
Immunomedics Reports Labetuzumab Govitecan is Active in Relapsed Metastatic Colorectal Cancer2 June 2015
U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports